Appeal No. 2006-0230 Page 5 Application No. 09/864,083 Appellants focus our attention (Brief, pages 5-7), on the fact that Gordon does not address the pH of the compositions disclosed therein. In this regard, appellants argue that since Gordon does not teach a pH of about 5.5 to about 8.0, Gordon does not teach all the limitations of appellants’ claimed invention and therefore cannot render appellants’ claimed invention prima facie obvious. Id. However, as we understand the examiner’s argument (Answer, page 4), compositions having similar ingredients would have a similar pH. Stated differently, given their similar ingredients, it would be reasonable to expect that the pH of Gordon’s compositions would inherently be the same as, or within, the range set forth in appellants’ claim. As set forth in In re Best, 562 F.2d 1252, 1255, 195 USPQ 430, 433-434 (CCPA 1977), footnote omitted: Where, as here, the claimed and prior art products are identical or substantially identical, … the PTO can require an applicant to prove that the prior art products do not necessarily or inherently possess the characteristics of his claimed product.... Whether the rejection is based on ‘inherency’ under 35 U.S.C. § 102, on ‘prima facie obviousness’ under 35 U.S.C. § 103, jointly or alternatively, the burden of proof is the same, and its fairness is evidenced by the PTO’s inability to manufacture products or to obtain and compare prior art products. Apparently recognizing the burden placed on them by Best, appellants direct our attention to Exhibit 1 of the Brief which lists U.S. Patents 5,889,054 (‘054), 5,962,526 (‘526), and 5,554,652 (‘652). Upon review of the three patents we note that the ‘652 patent is a continuation of United States Patent No. 5,470,880 (‘880). The ‘054 and ‘526 patents are both a continuation of United States Patent 5,691,378, which in turn is a continuation of the ‘880 patent. Therefore, all three patents cited by appellants have the same disclosure.Page: Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 NextLast modified: November 3, 2007